Search results
Researchers take step toward development of universal COVID-19 antibodies
Forrest City Times-Herald· 4 days agoSARS-CoV-2, the virus that causes COVID-19 disease, continues to evolve and evade current vaccine and therapeutic interventions. A consortium of scientists at Texas Biomedical ...
Monoclonal Antibody May Benefit Patients With Kidney Transplant Rejection
MedPage Today· 6 days agoAn investigational monoclonal antibody appeared to have therapeutic benefits among kidney transplant...
Epitope binning for multiple antibodies simultaneously using mammalian cell display and DNA...
Nature· 6 days agoAn epitope binning platform based on mammalian cell surface display and DNA sequencing enables the simultaneous binning of multiple antibodies without the need for antibody production and purification.
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 3 days agoFood and Drug Administration (FDA) on an expedient, repeatable immunobridging pathway to future potential emergency use authorizations (EUAs) for serial, novel monoclonal ...
Invivyd aligns with FDA on rapid mAb trial pathway By Investing.com
Investing.com· 3 days agoFood and Drug Administration (FDA) on a new clinical trial pathway for the expedited development of ...
Antibodies may aid effort to fight influenza B: st | Newswise
Newswise· 3 days agoResearchers at Vanderbilt University Medical Center have isolated human monoclonal antibodies against influenza B, a significant public health threat that disproportionately ...
Invivyd appoints new Chief Commercial Officer ahead of PEMGARDA launch By Investing.com
Investing.com· 3 days agoLee's extensive experience in the pharmaceutical industry is expected to enhance the company's...
EMA Panel Nods to Seven New Cancer Drugs
Medscape· 3 days agoThe drugs include an anti–PD-L1 monoclonal antibody, a biosimilar, and five generics, with indications covering a wide spectrum of cancers.
Gilead and Arcus Announce Etrumadenant Plus Zimberelimab Regimen Significantly Reduced the Risk of...
Morningstar· 1 day agoGilead and Arcus Announce EtrumadenantPlus Zimberelimab Regimen Significantly Reduced the Risk of Death in Third-line Metastatic Colorectal Cancer – In Cohort B of the ARC-9 mCRC Study, Etrumadenant ...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 4 days agoVitaGraft Kidney was used to monitor graft injury in a phase 2 double-blind, placebo-controlled study (NCT05021484) of the investigational drug felzartamab, a fully human CD38 monoclonal ...